Dearborn Partners LLC Bristol Myers Squibb CO Transaction History

Dearborn Partners LLC

$2.28 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$47.98 - $54.4 $98,646 - $111,846	-2,056 Reduced 24.85%	6,218 $337,000
Q4 2023 Jan 26, 2024	SELL	$48.48 - $57.85 $19,343 - $23,082	-399 Reduced 4.6%	8,274 $424,000
Q3 2023 Nov 01, 2023	SELL	$57.89 - $64.73 $14,588 - $16,311	-252 Reduced 2.82%	8,673 $503,000
Q2 2023 Aug 03, 2023	BUY	$63.71 - $70.74 $56,765 - $63,029	891 Added 11.09%	8,925 $570,000
Q1 2023 May 04, 2023	SELL	$65.71 - $74.53 $98,564 - $111,795	-1,500 Reduced 15.73%	8,034 $556,000
Q4 2022 Feb 02, 2023	BUY	$68.48 - $81.09 $81,696 - $96,740	1,193 Added 14.3%	9,534 $685,000
Q3 2022 Oct 25, 2022	SELL	$0.13 - $76.84 $32 - $19,286	-251 Reduced 2.92%	8,341 $593,000
Q2 2022 Jul 20, 2022	BUY	$72.62 - $79.98 $14,524 - $15,996	200 Added 2.38%	8,592 $662,000
Q1 2022 May 04, 2022	BUY	$61.48 - $73.72 $18,935 - $22,705	308 Added 3.81%	8,392 $613,000
Q4 2021 Jan 28, 2022	SELL	$53.63 - $62.52 $134,450 - $156,737	-2,507 Reduced 23.67%	8,084 $504,000
Q3 2021 Oct 27, 2021	SELL	$59.17 - $69.31 $13,313 - $15,594	-225 Reduced 2.08%	10,591 $627,000
Q2 2021 Jul 26, 2021	BUY	$61.91 - $67.42 $38,569 - $42,002	623 Added 6.11%	10,816 $723,000
Q1 2021 Apr 29, 2021	BUY	$59.34 - $66.74 $12,698 - $14,282	214 Added 2.14%	10,193 $643,000
Q4 2020 Jan 27, 2021	BUY	$57.74 - $65.43 $8,025 - $9,094	139 Added 1.41%	9,979 $619,000
Q3 2020 Oct 20, 2020	BUY	$57.43 - $63.64 $17,229 - $19,092	300 Added 3.14%	9,840 $593,000
Q2 2020 Jul 30, 2020	BUY	$54.82 - $64.09 $56,190 - $65,692	1,025 Added 12.04%	9,540 $561,000
Q1 2020 May 11, 2020	BUY	$46.4 - $67.43 $60,598 - $88,063	1,306 Added 18.12%	8,515 $475,000
Q4 2019 Jan 28, 2020	BUY	$49.21 - $64.19 $354,754 - $462,745	7,209 New	7,209 $463,000
Q1 2019 May 01, 2019	SELL	$45.12 - $53.8 $202,814 - $241,831	-4,495 Closed	0 $0
Q4 2018 Feb 04, 2019	BUY	$48.76 - $63.23 $219,176 - $284,218	4,495 New	4,495 $234,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dearborn Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dearborn Partners LLC with notifications on news.

Account